Compare · MVST vs TMO
MVST vs TMO
Side-by-side comparison of Microvast Holdings Inc. (MVST) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- MVST operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 658.4x MVST ($300.5M).
- Over the past year, MVST is down 73.2% and TMO is up 28.1% - TMO leads by 101.3 points.
- TMO has hit the wire 9 times in the past 4 weeks while MVST has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 6 for MVST).
- Company
- Microvast Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.91-2.22%
- $532.16-2.05%
- Market cap
- $300.5M
- $197.88B
- 1M return
- -27.54%
- +12.59%
- 1Y return
- -73.20%
- +28.12%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 0
- 9
- Recent ratings
- 6
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MVST
- Pres., Gen. Couns. & Corp. Sec Tushe Isida was granted 15,503 shares and sold $7,940 worth of shares (6,403 units at $1.24), increasing direct ownership by 5% to 184,100 units (SEC Form 4) (for tax liability)
- Chief Technology Officer Mattis Wenjuan sold $5,176 worth of shares (4,705 units at $1.10), decreasing direct ownership by 0.50% to 927,973 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Wu Yang sold $57,428 worth of shares (46,313 units at $1.24), decreasing direct ownership by 0.03% to 134,065,439 units (SEC Form 4) (for withholding tax)
- Chief Executive Officer Wu Yang converted options into 50,000,000 shares, increasing direct ownership by 59% to 134,111,752 units (SEC Form 4)
- Microvast Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
- Chief Technology Officer Mattis Wenjuan sold $63,817 worth of shares (48,346 units at $1.32), decreasing direct ownership by 5% to 932,678 units (SEC Form 4) (withholding tax)
- Microvast Reports First Quarter 2026 Financial Results
- Microvast Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Microvast Holdings Inc.
- Microvast Schedules First Quarter Earnings Call
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target